financetom
Business
financetom
/
Business
/
SKF sells non-core aerospace business in the U.S. to Carco PRP
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SKF sells non-core aerospace business in the U.S. to Carco PRP
Aug 17, 2025 11:33 PM

STOCKHOLM (Reuters) -Swedish bearings maker SKF said on Monday it had agreed to sell its non-core aerospace operation in Elgin in the U.S. to Carco PRP Group for a total estimated enterprise value of $70 million.

SKF said in a statement the sale of the precision elastomeric device (PED) operation is part a strategy to focus on its core aerospace areas and exit non-strategic business lines.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Stellantis Extends, Amends $13.12 Billion Credit Facility
Stellantis Extends, Amends $13.12 Billion Credit Facility
Jul 17, 2024
02:23 PM EDT, 07/17/2024 (MT Newswires) -- Stellantis ( STLA ) said Wednesday it has extended its 12 billion euros ($13.12 billion) syndicated revolving credit facility. The credit facility, originally signed in July 2021, involves 29 banks from Europe, America, and Asia. It is divided into two tranches: 6 billion euros with a three-year term and 6 billion euros with...
-- Altius Renewable Royalties Brief: Reporting Q2 2024 Expected Proportionate Royalty Revenue of US$1.5 million
-- Altius Renewable Royalties Brief: Reporting Q2 2024 Expected Proportionate Royalty Revenue of US$1.5 million
Jul 17, 2024
02:24 PM EDT, 07/17/2024 (MT Newswires) -- Price: 9.33, Change: -0.08, Percent Change: -0.85 ...
4D Molecular Therapeutics Goes Neck To Neck With Rival, Shares New Phase 2 Data For Its Wet AMD Candidate
4D Molecular Therapeutics Goes Neck To Neck With Rival, Shares New Phase 2 Data For Its Wet AMD Candidate
Jul 17, 2024
Wednesday, 4D Molecular Therapeutics, Inc. ( FDMT )unveiled interim 24-week data from the Population Extension cohort of its PRISM Phase 2 Clinical Trial. The trial evaluates intravitreal 4D-150 in a broad wet AMD patient population. Also Read: Why Is 4D Molecular Therapeutics Stock Trading Lower On Thursday? Genetic Disease-Focused Study Data Released. The findings were presented at the American Society...
Former Goldman, Blackstone analyst gets 28-month prison sentence for insider trading
Former Goldman, Blackstone analyst gets 28-month prison sentence for insider trading
Jul 17, 2024
NEW YORK, July 17 (Reuters) - A former Goldman Sachs and Blackstone analyst was sentenced to 28 months in prison on Wednesday for insider trading, after admitting that his conduct was catastrophically stupid. Anthony Viggiano, 27, of Baldwin, New York, was sentenced by U.S. District Judge Valerie Caproni in Manhattan, after pleading guilty in January to securities fraud. Viggiano was...
Copyright 2023-2026 - www.financetom.com All Rights Reserved